Akhil Santhosh, Medical Oncologist at AIIMS Delhi, shared a post on X:
“PATRICIA trial (Cohort C):
Combination of palbociclib + ET+ trastuzumab improves PFS compared to physicians’ choice (less than 10% got tdxd in PC).
OS data pending.
Similar results as in Monarch-HER.”
